Skip to content

Clinical trials

Completed Phase 1/2 Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1/2 Status: Completed Clear all

196 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20014
20024
20034
20049
20058
20069
20079
20089
200913
20104
201111
20129
201316
201414
201512
201615
20176
20183
20196
20205
20215
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed196

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center22
Fred Hutchinson Cancer Center15
National Cancer Institute (NCI)8
Washington University School of Medicine8
Astellas Pharma Global Development, Inc.4
PETHEMA Foundation4
H. Lee Moffitt Cancer Center and Research Institute3
Masonic Cancer Center, University of Minnesota3
Moleculin Biotech, Inc.3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute196
Myelodysplastic Syndromes71
Precursor Cell Lymphoblastic Leukemia-Lymphoma57
Leukemia56
Lymphoma, Non-Hodgkin28
Leukemia, Myelogenous, Chronic, BCR-ABL Positive25
Leukemia, Myelomonocytic, Chronic25
Hodgkin Disease24
Leukemia, Lymphocytic, Chronic, B-Cell23
Multiple Myeloma22

Trials

Showing 1 to 25 of 196. Each trial links to its page on Pharma Observatory.

96 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.